Goedegebuure PS - Search Results

1

T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.

Peoples GE, Davey MP, Goedegebuure PS, Schoof DD, Eberlein TJ. Peoples GE, et al. Among authors: goedegebuure ps. J Immunol. 1993 Nov 15;151(10):5472-80. J Immunol. 1993. PMID: 8228239

2

B7.1 costimulation increases T-cell proliferation and cytotoxicity via selective expansion of specific variable alpha and beta genes of the T-cell receptor.

Chan AK, Goedegebuure PS, von Bernstorff W, Carritte AL, Chung M, Stewart RA, Montgomery L, Spanjaard RA, McKenzie AB, Eberlein TJ. Chan AK, et al. Among authors: goedegebuure ps. Surgery. 2000 Mar;127(3):342-50. doi: 10.1067/msy.2000.104363. Surgery. 2000. PMID: 10715992

3

Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma.

Lockhart DC, Chan AK, Mak S, Joo HG, Daust HA, Carritte A, Douville CC, Goedegebuure PS, Eberlein TJ. Lockhart DC, et al. Among authors: goedegebuure ps. Surgery. 2001 Jun;129(6):749-56. doi: 10.1067/msy.2001.114554. Surgery. 2001. PMID: 11391375

4

Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer.

Linehan DC, Goedegebuure PS, Peoples GE, Rogers SO, Eberlein TJ. Linehan DC, et al. Among authors: goedegebuure ps. J Immunol. 1995 Nov 1;155(9):4486-91. J Immunol. 1995. PMID: 7594611

5

Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study.

Goedegebuure PS, Douville LM, Li H, Richmond GC, Schoof DD, Scavone M, Eberlein TJ. Goedegebuure PS, et al. J Clin Oncol. 1995 Aug;13(8):1939-49. doi: 10.1200/JCO.1995.13.8.1939. J Clin Oncol. 1995. PMID: 7636534 Clinical Trial.

6

Shared T cell epitopes in epithelial tumors.

Peoples GE, Smith RC, Linehan DC, Yoshino I, Goedegebuure PS, Eberlein TJ. Peoples GE, et al. Among authors: goedegebuure ps. Cell Immunol. 1995 Sep;164(2):279-86. doi: 10.1006/cimm.1995.1171. Cell Immunol. 1995. PMID: 7656335

7

Immunoregulatory effects of CD4+ T helper subsets in human melanoma.

Lee KY, Goedegebuure PS, Linehan DC, Eberlein TJ. Lee KY, et al. Among authors: goedegebuure ps. Surgery. 1995 Apr;117(4):365-72. doi: 10.1016/s0039-6060(05)80054-6. Surgery. 1995. PMID: 7716716

8

In vitro stimulation of ovarian tumour-associated lymphocytes with a peptide derived from HER2/neu induces cytotoxicity against autologous tumour.

Linehan DC, Peoples GE, Hess DT, Summerhayes IC, Parikh AS, Goedegebuure PS, Eberlein TJ. Linehan DC, et al. Among authors: goedegebuure ps. Surg Oncol. 1995 Feb;4(1):41-9. doi: 10.1016/s0960-7404(10)80030-1. Surg Oncol. 1995. PMID: 7780612

9

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.

Peoples GE, Goedegebuure PS, Smith R, Linehan DC, Yoshino I, Eberlein TJ. Peoples GE, et al. Among authors: goedegebuure ps. Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):432-6. doi: 10.1073/pnas.92.2.432. Proc Natl Acad Sci U S A. 1995. PMID: 7831305 Free PMC article.

10

Recruitment of host CD8+ T cells by tumor-infiltrating lymphocytes and recombinant interleukin-2 during adoptive immunotherapy of cancer.

Burger UL, Chang MP, Goedegebuure PS, Eberlein TJ, Adams-Hodgins S. Burger UL, et al. Among authors: goedegebuure ps. Surgery. 1995 Mar;117(3):325-33. doi: 10.1016/s0039-6060(05)80209-0. Surgery. 1995. PMID: 7878540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters